Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rhythm Pharmaceuticals Inc.

61.74
+0.40000.65%
Post-market: 61.740.00000.00%19:05 EDT
Volume:628.86K
Turnover:38.70M
Market Cap:3.90B
PE:-14.23
High:61.96
Open:61.11
Low:60.93
Close:61.34
Loading ...

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
06 Nov 2024

Stock Track | Rhythm Pharmaceuticals Soars 6.55% After Beating Q3 2024 Earnings Estimates

Stock Track
·
06 Nov 2024

Rhythm Pharmaceuticals Q3 2024 GAAP EPS $(0.73) Beats $(0.82) Estimate, Sales $33.251M Beat $32.517M Estimate

Benzinga
·
06 Nov 2024

BRIEF-Rhythm Pharmaceuticals Q3 Net Income USD -43.641 Million

Reuters
·
06 Nov 2024

Rhythm Pharmaceuticals Inc - Cash on-Hand Expected to Support Planned Operations Into 2026

THOMSON REUTERS
·
06 Nov 2024

Rhythm Pharmaceuticals Inc - Qtrly Net Loss per Basic and Diluted Share of $0.73

THOMSON REUTERS
·
06 Nov 2024

Stifel Nicolaus Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
04 Nov 2024

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know

Zacks
·
31 Oct 2024

Rhythm Pharmaceuticals Price Target Maintained With a $55.00/Share by Needham

Dow Jones
·
30 Oct 2024

ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

Zacks
·
28 Oct 2024

Rhythm Pharmaceuticals Price Target Maintained With a $64.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Oct 2024

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

THOMSON REUTERS
·
24 Oct 2024

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

GlobeNewswire
·
24 Oct 2024

Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral

seekingalpha
·
22 Oct 2024

Guggenheim Initiates Coverage on Rhythm Pharmaceuticals With Buy Rating, $70 Price Target

MT Newswires Live
·
21 Oct 2024